| Year |
Citation |
Score |
| 2023 |
Almkvist O, Larsson M, Graff C. Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 38160354 DOI: 10.3233/JAD-230618 |
0.312 |
|
| 2023 |
Almkvist O, Nordberg A. A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer's disease. Alzheimer's Research & Therapy. 15: 89. PMID 37131241 DOI: 10.1186/s13195-023-01231-8 |
0.514 |
|
| 2022 |
Almkvist O, Graff C. Practice effects in cognitive assessments three years later in non-carriers but not in symptom-free mutation carriers of autosomal-dominant Alzheimer's disease: Exemplifying procedural learning and memory? Frontiers in Aging Neuroscience. 14: 905329. PMID 36275006 DOI: 10.3389/fnagi.2022.905329 |
0.356 |
|
| 2022 |
Almkvist O, Johansson C, Laffita-Mesa J, Thordardottir S, Graff C. APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal-dominant Alzheimer's disease. European Journal of Neurology. PMID 36039401 DOI: 10.1111/ene.15536 |
0.384 |
|
| 2021 |
Almkvist O, Graff C. The ε4 Allele Affects Cognitive Functions Differently in Carriers of Mutations Compared to Carriers of Mutations in Autosomal-Dominant Alzheimer's Disease. Genes. 12. PMID 34946903 DOI: 10.3390/genes12121954 |
0.321 |
|
| 2021 |
Almkvist O, Brüggen K, Nordberg A. Subcortical and Cortical Regions of Amyloid-β Pathology Measured by 11C-PiB PET Are Differentially Associated with Cognitive Functions and Stages of Disease in Memory Clinic Patients. Journal of Alzheimer's Disease : Jad. PMID 33967046 DOI: 10.3233/JAD-201612 |
0.549 |
|
| 2020 |
Thordardottir S, Almkvist O, Johansson C, Zetterberg H, Blennow K, Graff C. Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 32568193 DOI: 10.3233/Jad-191261 |
0.445 |
|
| 2020 |
Vilaplana E, Rodriguez-Vieitez E, Ferreira D, Montal V, Almkvist O, Wall A, Lleó A, Westman E, Graff C, Fortea J, Nordberg A. Cortical microstructural correlates of astrocytosis in autosomal dominant Alzheimer disease. Neurology. PMID 32291295 DOI: 10.1212/Wnl.0000000000009405 |
0.596 |
|
| 2019 |
Karami A, Eriksdotter M, Kadir A, Almkvist O, Nordberg A, Darreh-Shori T. CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer's Disease. Frontiers in Molecular Neuroscience. 12: 239. PMID 31680850 DOI: 10.3389/Fnmol.2019.00239 |
0.559 |
|
| 2019 |
Almkvist O, Rodriguez-Vieitez E, Thordardottir S, Nordberg A, Viitanen M, Lannfelt L, Graff C. Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes. Neurobiology of Aging. 82: 40-47. PMID 31386938 DOI: 10.1016/J.Neurobiolaging.2019.06.010 |
0.543 |
|
| 2019 |
Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E, Nordberg A. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Molecular Psychiatry. PMID 30635637 DOI: 10.1038/S41380-018-0342-8 |
0.763 |
|
| 2019 |
Karami A, Eriksdotter M, Kadir A, Almkvist O, Nordberg AK, Darreh-Shori T. P2-109: Csf Cholinergic Index, A New Biomeasure Of Treatment Effect In Patients With Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2516 |
0.417 |
|
| 2018 |
Chiotis K, Stenkrona P, Almkvist O, Stepanov V, Ferreira D, Arakawa R, Takano A, Westman E, Varrone A, Okamura N, Shimada H, Higuchi M, Halldin C, Nordberg A. Dual tracer tau PET imaging reveals different molecular targets for C-THK5351 and C-PBB3 in the Alzheimer brain. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29752516 DOI: 10.1007/S00259-018-4012-5 |
0.757 |
|
| 2018 |
Thordardottir S, Rodriguez-Vieitez E, Almkvist O, Ferreira D, Saint-Aubert L, Kinhult-Ståhlbom A, Thonberg H, Schöll M, Westman E, Wall A, Eriksdotter M, Zetterberg H, Blennow K, Nordberg A, Graff C. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study. Alzheimer's Research & Therapy. 10: 45. PMID 29747683 DOI: 10.1186/S13195-018-0374-Y |
0.689 |
|
| 2018 |
Hedman A, Kottorp A, Almkvist O, Nygård L. Challenge levels of everyday technologies as perceived over five years by older adults with mild cognitive impairment. International Psychogeriatrics. 1-8. PMID 29615145 DOI: 10.1017/S1041610218000285 |
0.357 |
|
| 2018 |
Vilaplana E, Rodriguez-Vieitez E, Ferreira D, Montal V, Almkvist O, Wall A, Graff C, Westman E, Fortea J, Nordberg AK. O5-01-04: Early Inflammation And Microstructural Cortical Changes In Familial Autosomal-Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2998 |
0.363 |
|
| 2017 |
Leuzy A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G, Nordberg A. Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29268078 DOI: 10.1016/J.Jalz.2017.11.008 |
0.816 |
|
| 2017 |
Stormoen S, Tallberg IM, Almkvist O, Eriksdotter M, Sundström E. Decisions and attitudes regarding participation and proxy in clinical trials among patients with impaired cognitive function. Dementia (London, England). 18: 2049-2061. PMID 29141449 DOI: 10.1177/1471301217737413 |
0.366 |
|
| 2017 |
Thalén L, Heimann Mühlenbock K, Almkvist O, Eriksdotter M, Sundström E, Tallberg IM. Do adapted vignettes improve medical decision-making capacity for individuals with Alzheimer's disease? Scandinavian Journal of Psychology. 58: 497-503. PMID 29105128 DOI: 10.1111/Sjop.12401 |
0.372 |
|
| 2017 |
Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. Journal of Alzheimer's Disease : Jad. 59: 603-614. PMID 28671117 DOI: 10.3233/Jad-170158 |
0.786 |
|
| 2017 |
Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G, Nordberg A. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia. Molecular Psychiatry. 23: 1666-1673. PMID 28507319 DOI: 10.1038/Mp.2017.108 |
0.845 |
|
| 2017 |
Thordardottir S, Kinhult Ståhlbom A, Almkvist O, Thonberg H, Eriksdotter M, Zetterberg H, Blennow K, Graff C. The effects of different familial Alzheimer's disease mutations on APP processing in vivo. Alzheimer's Research & Therapy. 9: 9. PMID 28209190 DOI: 10.1186/S13195-017-0234-1 |
0.456 |
|
| 2017 |
Almkvist O, Rodriguez-Vieitez E, Thordardottir S, Amberla K, Axelman K, Basun H, Kinhult-Ståhlbom A, Lilius L, Remes A, Wahlund LO, Viitanen M, Lannfelt L, Graff C. Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease. Journal of the International Neuropsychological Society : Jins. 1-9. PMID 28079014 DOI: 10.1017/S1355617716001028 |
0.43 |
|
| 2017 |
Almkvist O, Rodriguez-Vieitez E, Thordardottir S, Ståhlbom AK, Viitanen M, Lannfelt L, Graff C. GENOTYPE-DEPENDENT LONGITUDINAL TRAJECTORIES OF COGNITIVE DECLINE IN AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE Alzheimer's & Dementia. 13: P1554. DOI: 10.1016/J.Jalz.2017.07.695 |
0.389 |
|
| 2017 |
Chiotis K, Stenkrona P, Almkvist O, Arakawa R, Takano A, Stepanov V, Varrone A, Higuchi M, Halldin C, Nordberg A. [IC-P-178]: HEAD-TO-HEAD IN VIVO
COMPARISON OF TAU-SPECIFIC PET TRACERS IN ALZHEIMER's DISEASE: [11
C]THK5351 VERSUS [11
C]PBB3 PET IMAGING Alzheimer's & Dementia. 13: P133-P133. DOI: 10.1016/J.Jalz.2017.06.2553 |
0.772 |
|
| 2017 |
Chiotis K, Stenkrona P, Almkvist O, Arakawa R, Takano A, Stepanov V, Varrone A, Higuchi M, Halldin C, Nordberg A. [P2-366]: HEAD-TO-HEAD IN VIVO
COMPARISON OF TAU-SPECIFIC PET TRACERS IN ALZHEIMER's DISEASE: [11
C]THK5351 VERSUS [11
C]PBB3 PET IMAGING Alzheimer's & Dementia. 13: P765-P765. DOI: 10.1016/j.jalz.2017.06.1021 |
0.557 |
|
| 2016 |
Li X, Westman E, Thordardottir S, Ståhlbom AK, Almkvist O, Blennow K, Wahlund LO, Graff C. The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27911308 DOI: 10.3233/Jad-160730 |
0.472 |
|
| 2016 |
Saint-Aubert L, Almkvist O, Chiotis K, Almeida R, Wall A, Nordberg A. Regional tau deposition measured by [(18)F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease. Alzheimer's Research & Therapy. 8: 38. PMID 27683159 DOI: 10.1186/S13195-016-0204-Z |
0.846 |
|
| 2016 |
Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, et al. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device. Alzheimer's Research & Therapy. 8: 30. PMID 27389402 DOI: 10.1186/S13195-016-0195-9 |
0.501 |
|
| 2016 |
Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Jonasson M, Eriksson J, Lubberink M, Almkvist O, Wall A, Antoni G, Nordberg A. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm. European Journal of Nuclear Medicine and Molecular Imaging. 43: 1686-99. PMID 26996778 DOI: 10.1007/S00259-016-3363-Z |
0.832 |
|
| 2016 |
Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A. Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-PiB PET for Assessing Brain Perfusion in Alzheimer's Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912447 DOI: 10.2967/Jnumed.115.168732 |
0.803 |
|
| 2016 |
Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Graff C, Wall A, Långström B, Nordberg A. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 26813969 DOI: 10.1093/Brain/Awv404 |
0.824 |
|
| 2016 |
Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Almkvist O, Wall A, Nordberg A. Early-Phase [11C]Pib Pet Is Comparable To [18F]Fdg Pet As A Marker Of Disease Progression In Alzheimer'S Disease Alzheimers & Dementia. 12: 1171. DOI: 10.1016/J.Jalz.2016.07.094 |
0.826 |
|
| 2016 |
Nordberg A, Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Almkvist O, Wall A, Antoni G. Longitudinal Changes In Regional Tau Deposition In Alzheimer'S Disease And Other Tauopathies Measured By [18F]-Tkh5317 Pet In A Multi-Tracer Design Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.645 |
0.824 |
|
| 2016 |
Saint-Aubert L, Chiotis K, Wall A, Almkvist O, Nordberg A. P1-306: Association Between in Vivo TAU Deposition Measured Using [18F]THK5317 Pet and Cognitive Functions in Alzheimer's Disease Alzheimer's & Dementia. 12: P539-P540. DOI: 10.1016/J.Jalz.2016.06.1056 |
0.837 |
|
| 2015 |
Schöll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography. Scientific Reports. 5: 16404. PMID 26553227 DOI: 10.1038/Srep16404 |
0.782 |
|
| 2015 |
Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H. Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment. Journal of Alzheimer's Disease : Jad. 47: 691-704. PMID 26401704 DOI: 10.3233/Jad-132474 |
0.614 |
|
| 2015 |
Farid K, Carter SF, Rodriguez-Vieitez E, Almkvist O, Andersen P, Wall A, Blennow K, Portelius E, Zetterberg H, Nordberg A. Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition. Journal of Alzheimer's Disease : Jad. 47: 661-7. PMID 26401701 DOI: 10.3233/Jad-141965 |
0.775 |
|
| 2015 |
Leuzy A, Carter SF, Chiotis K, Almkvist O, Wall A, Nordberg A. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 1077-88. PMID 25649653 DOI: 10.3233/Jad-142952 |
0.849 |
|
| 2015 |
Li X, Westman E, Ståhlbom AK, Thordardottir S, Almkvist O, Blennow K, Wahlund LO, Graff C. White matter changes in familial Alzheimer's disease. Journal of Internal Medicine. 278: 211-8. PMID 25639959 DOI: 10.1111/Joim.12352 |
0.403 |
|
| 2015 |
Hedman A, Nygård L, Almkvist O, Kottorp A. Corrigendum. Patterns of functioning in older adults with mild cognitive impairment: a two-year study focusing on everyday technology use. Aging & Mental Health. 19: 569. PMID 25584677 DOI: 10.1080/13607863.2014.1000559 |
0.304 |
|
| 2015 |
Hedman A, Nygård L, Almkvist O, Kottorp A. Amount and type of everyday technology use over time in older adults with cognitive impairment. Scandinavian Journal of Occupational Therapy. 22: 196-206. PMID 25580938 DOI: 10.3109/11038128.2014.982172 |
0.301 |
|
| 2015 |
Thordardottir S, Ståhlbom AK, Ferreira D, Almkvist O, Westman E, Zetterberg H, Eriksdotter M, Blennow K, Graff C. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 43: 1393-402. PMID 25182737 DOI: 10.3233/Jad-140339 |
0.455 |
|
| 2015 |
Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Blennow K, Langstrom B, Zetterberg H. Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment Journal of Alzheimer's Disease. 47: 691-704. DOI: 10.3233/JAD-132474 |
0.474 |
|
| 2015 |
Rodriguez-Vieitez E, Carter SF, Saint-Aubert L, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. O1-02-03: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal-dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 11: P127-P127. DOI: 10.1016/j.jalz.2015.07.035 |
0.677 |
|
| 2015 |
Rodriguez-Vieitez E, Carter SF, Saint-Aubert L, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. IC-P-126: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal-dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 11: P86-P86. DOI: 10.1016/J.Jalz.2015.06.148 |
0.82 |
|
| 2015 |
Hedman A, Nygård L, Malinowsky C, Almkvist O, Kottorp A. Changing everyday activities and technology use in mild cognitive impairment British Journal of Occupational Therapy. 79: 111-119. DOI: 10.1016/J.Apmr.2016.08.282 |
0.333 |
|
| 2014 |
Almkvist O, Kadir A, Nordberg A. Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case. Neurocase. 1-10. PMID 25494540 DOI: 10.1080/13554794.2014.979835 |
0.639 |
|
| 2014 |
Stormoen S, Almkvist O, Eriksdotter M, Sundström E, Tallberg IM. Cognitive predictors of medical decision-making capacity in mild cognitive impairment and Alzheimer's disease. International Journal of Geriatric Psychiatry. 29: 1304-11. PMID 24737535 DOI: 10.1002/Gps.4114 |
0.427 |
|
| 2014 |
Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. P3-215: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P709-P710. DOI: 10.1016/j.jalz.2014.05.1306 |
0.686 |
|
| 2014 |
Eyjolfsdottir H, Per A, Lind G, Linderoth B, Karami A, Almkvist O, Andreasen N, Blennow K, Jelic V, Nordberg A, Sundström E, Wahlund L, Wall A, Wiberg MK, Winblad B, et al. Encapsulated Cell Biodelivery Of Ngf To Cholinergic Basal Forebrain In Alzheimer'S Disease Patients: A Dose-Escalation Study Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1063 |
0.519 |
|
| 2014 |
Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. IC-P-019: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P16-P16. DOI: 10.1016/J.Jalz.2014.05.023 |
0.697 |
|
| 2013 |
Tallberg IM, Stormoen S, Almkvist O, Eriksdotter M, Sundström E. Investigating medical decision-making capacity in patients with cognitive impairment using a protocol based on linguistic features. Scandinavian Journal of Psychology. 54: 386-92. PMID 23841467 DOI: 10.1111/Sjop.12068 |
0.342 |
|
| 2013 |
Darreh-Shori T, Vijayaraghavan S, Aeinehband S, Piehl F, Lindblom RP, Nilsson B, Ekdahl KN, Långström B, Almkvist O, Nordberg A. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease. Neurobiology of Aging. 34: 2465-81. PMID 23759148 DOI: 10.1016/J.Neurobiolaging.2013.04.027 |
0.506 |
|
| 2013 |
Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, Boada M, Bullock R, De Deyn PP, Frisoni GB, Hampel H, Jones RW, Kehoe P, Lenoir H, Minthon L, et al. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study. Dementia and Geriatric Cognitive Disorders. 36: 1-19. PMID 23651945 DOI: 10.1159/000348354 |
0.427 |
|
| 2013 |
Hedman A, Nygård L, Almkvist O, Kottorp A. Patterns of functioning in older adults with mild cognitive impairment: a two-year study focusing on everyday technology use. Aging & Mental Health. 17: 679-88. PMID 23550598 DOI: 10.1080/13607863.2013.777396 |
0.353 |
|
| 2013 |
Persson N, Viitanen M, Almkvist O, Wahlin Å. A principal component model of medical health: implications for cognitive deficits and decline among adults in a population-based sample. Journal of Health Psychology. 18: 1268-87. PMID 23180878 DOI: 10.1177/1359105312459877 |
0.31 |
|
| 2013 |
Choo IH, Ni R, Schöll M, Wall A, Almkvist O, Nordberg A. Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients. Journal of Alzheimer's Disease : Jad. 33: 929-39. PMID 23047371 DOI: 10.3233/Jad-2012-121489 |
0.644 |
|
| 2013 |
Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, Långström B, Scheinin N, Karrasch M, Någren K, Grimmer T, Miederer I, Edison P, ... ... Almkvist O, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 40: 104-14. PMID 22961445 DOI: 10.1007/S00259-012-2237-2 |
0.773 |
|
| 2013 |
Enache D, Almkvist O, Kramberger MG, Jelic V, Eriksdotter M, Lebedeva A, Göthe F, Winblad B, Aarsland D. 1621 – Depressive symptoms and cognitive functioning in elderly European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)76616-1 |
0.387 |
|
| 2013 |
Thordardottir S, Kinhult-Ståhlbom A, Almkvist O, Jonhagen ME, Zetterberg H, Blennow K, Graff C. P1-203: The effects of gene mutations on the cerebrospinal fluid levels of soluble amyloid precursor proteins in familial Alzheimer's disease Alzheimer's & Dementia. 9: P226-P227. DOI: 10.1016/J.Jalz.2013.05.427 |
0.388 |
|
| 2013 |
Schöll M, Carter S, Westman E, Almkvist O, Wall A, Graff C, Långström B, Nordberg A. O4-07-02: Longitudinal multi-tracer positron emission tomography studies of astrocytosis, fibrillar amlyloid deposition and cerebral glucose metabolism during development of early-onset familial Alzheimer's disease Alzheimer's & Dementia. 9: P695-P695. DOI: 10.1016/J.Jalz.2013.04.372 |
0.724 |
|
| 2012 |
Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, Långström B, Almkvist O, Graff C, Nordberg A. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology. 79: 229-36. PMID 22700814 DOI: 10.1212/Wnl.0B013E31825Fdf18 |
0.582 |
|
| 2012 |
Eriksdotter-Jönhagen M, Linderoth B, Lind G, Aladellie L, Almkvist O, Andreasen N, Blennow K, Bogdanovic N, Jelic V, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, et al. Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 33: 18-28. PMID 22377499 DOI: 10.1159/000336051 |
0.561 |
|
| 2012 |
Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 37-46. PMID 22213821 DOI: 10.2967/Jnumed.110.087031 |
0.775 |
|
| 2012 |
Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Långström B, Nordberg A. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease. Neurobiology of Aging. 33: 198.e1-14. PMID 20688420 DOI: 10.1016/J.Neurobiolaging.2010.06.015 |
0.678 |
|
| 2011 |
Ausén B, Edman G, Almkvist O, Bogdanovic N. Self- and informant ratings of personality in mild cognitive impairment, reviewed. Dementia and Geriatric Cognitive Disorders. 32: 387-93. PMID 22301462 DOI: 10.1159/000330695 |
0.352 |
|
| 2011 |
Norberg J, Graff C, Almkvist O, Ewers M, Frisoni GB, Frölich L, Hampel H, Jones RW, Kehoe PG, Lenoir H, Minthon L, Nobili F, Olde Rikkert M, Rigaud AS, Scheltens P, et al. Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects. Dementia and Geriatric Cognitive Disorders. 32: 135-42. PMID 21952537 DOI: 10.1159/000330492 |
0.42 |
|
| 2011 |
Schöll M, Almkvist O, Bogdanovic N, Wall A, Långström B, Viitanen M, Nordberg A. Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers. Journal of Alzheimer's Disease : Jad. 24: 495-506. PMID 21297272 DOI: 10.3233/Jad-2011-101563 |
0.583 |
|
| 2011 |
Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Brain : a Journal of Neurology. 134: 301-17. PMID 21149866 DOI: 10.1093/Brain/Awq349 |
0.585 |
|
| 2011 |
Malinowsky C, Almkvist O, Kottorp A, Nygård L. Ability to manage everyday technology: a comparison of persons with dementia or mild cognitive impairment and older adults without cognitive impairment. Disability and Rehabilitation. Assistive Technology. 5: 462-9. PMID 20545577 DOI: 10.3109/17483107.2010.496098 |
0.354 |
|
| 2011 |
Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, Långström B, Nordberg A. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiology of Aging. 32: 2320.e15-32. PMID 20538374 DOI: 10.1016/J.Neurobiolaging.2010.04.028 |
0.619 |
|
| 2011 |
Schöll M, Almkvist O, Axelman K, Stefanova E, Wall A, Westman E, Långström B, Lannfelt L, Graff C, Nordberg A. Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. Neurobiology of Aging. 32: 1388-99. PMID 19796846 DOI: 10.1016/J.Neurobiolaging.2009.08.016 |
0.616 |
|
| 2011 |
Schöll M, Almkvist O, Graff C, Nordberg A. O2-06-08: Amyloid imaging in members of a family harbouring the Arctic APP mutation Alzheimer's & Dementia. 7: S303-S303. DOI: 10.1016/J.Jalz.2011.05.880 |
0.451 |
|
| 2011 |
Carter SF, Nordberg A, Schöll M, Almkvist O, Wall A, Engler H, Långström B. O1-07-05: Investigating astrocytosis with 11C-deuterium-L-Deprenyl in mild cognitive impairment and mild Alzheimer's disease: A multi tracer PET paradigm combining 11C-PIB and 18F-FDG Alzheimer's & Dementia. 7: S110-S110. DOI: 10.1016/J.Jalz.2011.05.276 |
0.764 |
|
| 2010 |
Ek L, Almkvist O, Wiberg MK, Stragliotto G, Smits A. Early cognitive impairment in a subset of patients with presumed low-grade glioma. Neurocase. 16: 503-11. PMID 20521201 DOI: 10.1080/13554791003730634 |
0.394 |
|
| 2010 |
Forsberg A, Almkvist O, Engler H, Wall A, Långström B, Nordberg A. High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters. Current Alzheimer Research. 7: 56-66. PMID 20205671 DOI: 10.2174/156720510790274446 |
0.631 |
|
| 2010 |
Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A. P4-089: Investigating Astrocytes With C11-deuterium Deprenyl in Mild Cognitive Impairment and Mild Alzheimer's - A Multi-tracer Positron Emission Tomography Paradigm Alzheimer's & Dementia. 6: e48-e49. DOI: 10.1016/J.Jalz.2010.08.149 |
0.752 |
|
| 2010 |
Schöll M, Almkvist O, Wall A, Engler H, Kinhult-Ståhlbom A, Graff C, Nordberg A. Multitracer PET studies in kindreds with early-onset familial Alzheimer gene mutations Alzheimer's & Dementia. 6: S294. DOI: 10.1016/J.Jalz.2010.05.965 |
0.536 |
|
| 2009 |
Ausén B, Edman G, Almkvist O, Bogdanovic N. Personality features in subjective cognitive impairment and mild cognitive impairment--early indicators of dementia? Dementia and Geriatric Cognitive Disorders. 28: 528-35. PMID 20016183 DOI: 10.1159/000255104 |
0.378 |
|
| 2009 |
Almkvist O, Tallberg IM. Cognitive decline from estimated premorbid status predicts neurodegeneration in Alzheimer's disease. Neuropsychology. 23: 117-24. PMID 19210039 DOI: 10.1037/A0014074 |
0.443 |
|
| 2009 |
Nordberg A, Forsberg A, Kadir A, Almkvist O, Engler H, Långström B. S.4.02 Time course in evolution of brain amyloid and its relation to cognitive impairment in Alzheimer's disease European Neuropsychopharmacology. 19: S125-S126. DOI: 10.1016/S0924-977X(09)70133-6 |
0.544 |
|
| 2009 |
Kadir A, Zetterberg H, Andreasen N, Almkvist O, Wall A, Forsberg A, Blennow K, Långström B, Nordberg A. IC-O2-03: Long-term effect of phenserine treatment in Alzheimer patients as assessed by PET and CSF biomarkers Alzheimer's & Dementia. 5: P6-P6. DOI: 10.1016/J.Jalz.2009.05.019 |
0.523 |
|
| 2009 |
Nordberg A, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Almkvist O, Scheinin N, Grimmer T, Okello A, Van Laere K, Hinz R, Carter SF, Kalbe E, Herholz K. IC-S1-03: PET Amyloid imaging and cognition in patients with Alzheimer's disease, Mild Cognitive Impairment (MCI) and healthy controls: a European multicenter study Alzheimer's & Dementia. 5: P2-P2. DOI: 10.1016/J.Jalz.2009.05.006 |
0.759 |
|
| 2008 |
Larsson MU, Almkvist O, Luszcz MA, Wahlin TB. Phonemic fluency deficits in asymptomatic gene carriers for Huntington's disease. Neuropsychology. 22: 596-605. PMID 18763879 DOI: 10.1037/0894-4105.22.5.596 |
0.318 |
|
| 2008 |
Vannini P, Lehmann C, Dierks T, Jann K, Viitanen M, Wahlund LO, Almkvist O. Failure to modulate neural response to increased task demand in mild Alzheimer's disease: fMRI study of visuospatial processing. Neurobiology of Disease. 31: 287-97. PMID 18619845 DOI: 10.1016/J.Nbd.2008.04.013 |
0.399 |
|
| 2008 |
Basun H, Bogdanovic N, Ingelsson M, Almkvist O, Näslund J, Axelman K, Bird TD, Nochlin D, Schellenberg GD, Wahlund LO, Lannfelt L. Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease. Archives of Neurology. 65: 499-505. PMID 18413473 DOI: 10.1001/Archneur.65.4.499 |
0.369 |
|
| 2008 |
Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, Hagman G, Lärksäter M, Winblad B, Zetterberg H, Blennow K, Långström B, Nordberg A. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Annals of Neurology. 63: 621-31. PMID 18300284 DOI: 10.1002/Ana.21345 |
0.617 |
|
| 2008 |
Andersson C, Blennow K, Almkvist O, Andreasen N, Engfeldt P, Johansson SE, Lindau M, Eriksdotter-Jönhagen M. Increasing CSF phospho-tau levels during cognitive decline and progression to dementia. Neurobiology of Aging. 29: 1466-73. PMID 17512092 DOI: 10.1016/J.Neurobiolaging.2007.03.027 |
0.435 |
|
| 2008 |
Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, Långström B, Nordberg A. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiology of Aging. 29: 1456-65. PMID 17499392 DOI: 10.1016/J.Neurobiolaging.2007.03.029 |
0.658 |
|
| 2008 |
Kadir A, Darreh-Shori T, Almkvist O, Wall A, Grut M, Strandberg B, Ringheim A, B Eriksson, Blomquist G, Långström B, Nordberg A. PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD. Neurobiology of Aging. 29: 1204-17. PMID 17379359 DOI: 10.1016/J.Neurobiolaging.2007.02.020 |
0.556 |
|
| 2008 |
Darreh-Shori T, Kadir A, Almkvist O, Grut M, Wall A, Blomquist G, Eriksson B, Långström B, Nordberg A. Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine. Neurobiology of Aging. 29: 168-84. PMID 17196712 DOI: 10.1016/J.Neurobiolaging.2006.09.020 |
0.554 |
|
| 2008 |
Schöll M, Stefanova E, Almkvist O, Axelman K, Wall A, Långström B, Lannfelt L, Viitanen M, Nordberg A. IC-P2-134: FDG-PET studies in early-onset familial Alzheimer's disease Alzheimer's & Dementia. 4: T60-T60. DOI: 10.1016/J.Jalz.2008.05.2589 |
0.592 |
|
| 2008 |
Almkvist O, Forsberg A, Nordberg A. P3-105: Low episodic memory performance is related to high PET PIB levels in asymptomatic control subjects Alzheimer's & Dementia. 4: T549-T549. DOI: 10.1016/J.Jalz.2008.05.1670 |
0.49 |
|
| 2008 |
Schöll M, Stefanova E, Almkvist O, Axelman K, Wall A, Långström B, Lannfelt L, Viitanen M, Nordberg A. P2-075: FDG-PET studies in early-onset familial Alzheimer's disease Alzheimer's & Dementia. 4: T390-T390. DOI: 10.1016/J.Jalz.2008.05.1148 |
0.607 |
|
| 2008 |
Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. P2-026: Interrelation between cortical nicotinic receptors and acetylcholinesterase activity in mild Alzheimer's patients as assessed by PET Alzheimer's & Dementia. 4: T375-T375. DOI: 10.1016/J.Jalz.2008.05.1106 |
0.556 |
|
| 2008 |
Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. IC-P2-107: Interrelation between cortical nicotinic receptors and acetylcholinesterase activity in mild Alzheimer's patients as assessed by PET Alzheimer's & Dementia. 4: T50-T50. DOI: 10.1016/J.Jalz.2008.05.100 |
0.54 |
|
| 2008 |
Nordberg AK, Forsberg A, Almkvist O, Engler H, Wall A, Långström B. IC-03-02: Brain amyloid deposition in Alzheimer′s disease is an early event with complex relationship with functional characteristics Alzheimer's & Dementia. 4: T6-T7. DOI: 10.1016/J.Jalz.2008.05.007 |
0.331 |
|
| 2007 |
Vannini P, Almkvist O, Dierks T, Lehmann C, Wahlund LO. Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial processing. Psychiatry Research. 156: 43-57. PMID 17719211 DOI: 10.1016/J.Pscychresns.2007.02.003 |
0.435 |
|
| 2007 |
Almkvist O, Adveen M, Henning L, Tallberg IM. Estimation of premorbid cognitive function based on word knowledge: the Swedish Lexical Decision Test (SLDT). Scandinavian Journal of Psychology. 48: 271-9. PMID 17518919 DOI: 10.1111/J.1467-9450.2007.00575.X |
0.359 |
|
| 2007 |
Claesson IM, Ytterberg C, Johansson S, Almkvist O, von Koch L. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test. Multiple Sclerosis (Houndmills, Basingstoke, England). 13: 272-4. PMID 17439898 DOI: 10.1177/1352458506071167 |
0.327 |
|
| 2007 |
Kadir A, Darreh-Shori T, Almkvist O, Wall A, Långström B, Nordberg A. Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET. Psychopharmacology. 191: 1005-14. PMID 17310387 DOI: 10.1007/S00213-007-0725-Z |
0.607 |
|
| 2007 |
Bergendal G, Fredrikson S, Almkvist O. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study. European Neurology. 57: 193-202. PMID 17272938 DOI: 10.1159/000099158 |
0.321 |
|
| 2007 |
Andersson C, Blennow K, Johansson SE, Almkvist O, Engfeldt P, Lindau M, Eriksdotter-Jönhagen M. Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment. Dementia and Geriatric Cognitive Disorders. 23: 87-95. PMID 17124416 DOI: 10.1159/000097354 |
0.403 |
|
| 2007 |
Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM, Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, et al. Disease mechanisms in neuroscience Neuroscientist. 13: 99. DOI: 10.1177/10738584070130020301 |
0.475 |
|
| 2006 |
Tallberg IM, Wenneborg K, Almkvist O. Reading words with irregular decoding rules: a test of premorbid cognitive function? Scandinavian Journal of Psychology. 47: 531-9. PMID 17107502 DOI: 10.1111/J.1467-9450.2006.00547.X |
0.3 |
|
| 2006 |
Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism. Neurobiology of Disease. 24: 326-33. PMID 16973370 DOI: 10.1016/J.Nbd.2006.07.013 |
0.611 |
|
| 2006 |
Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain : a Journal of Neurology. 129: 2856-66. PMID 16854944 DOI: 10.1093/Brain/Awl178 |
0.669 |
|
| 2006 |
Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology. 188: 509-20. PMID 16832659 DOI: 10.1016/J.Neuroimage.2006.04.135 |
0.591 |
|
| 2006 |
Andersson C, Lindau M, Almkvist O, Engfeldt P, Johansson SE, Eriksdotter Jonhagen M. Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients. Dementia and Geriatric Cognitive Disorders. 21: 251-9. PMID 16465053 DOI: 10.1159/000091398 |
0.325 |
|
| 2006 |
Stefanova E, Wall A, Almkvist O, Nilsson A, Forsberg A, Långström B, Nordberg A. Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 113: 205-18. PMID 16049637 DOI: 10.1007/S00702-005-0312-6 |
0.614 |
|
| 2006 |
Andersson C, Blennow K, Lindau M, Almkvist O, Engfeldt P, Erik Johansson S, Eriksdotter-Jönhagen M. P2-158: Cognitive decline and longitudinal measurements of CSF tau and AB42 Alzheimer's & Dementia. 2: S280-S280. DOI: 10.1016/J.Jalz.2006.05.996 |
0.391 |
|
| 2006 |
Eriksdotter-Jönhagen M, Andersson C, Almkvist O, Engfeldt P, Lindau M, Johansson S, Blennow K. P2-151: ApoE-4 carriers but not ApoE-4 non-carriers with severe memory impairment show pathological tau, phospho-tau and B-amyloid levels in CSF Alzheimer's & Dementia. 2: S277-S278. DOI: 10.1016/J.Jalz.2006.05.989 |
0.388 |
|
| 2006 |
Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. P2-136: Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE ϵ4 allele, in relation to cognitive function and cerebral glucose metabolism Alzheimer's & Dementia. 2: S273-S273. DOI: 10.1016/J.Jalz.2006.05.974 |
0.592 |
|
| 2006 |
Nordberg AK, Forsberg A, Engler H, Almkvist O, Hagman G, Wall A, Blomquist G, Långström B. IC-103-01: PIB amyloid imaging in brain of AD and MCI patients-relation to CSF markers and cognition Alzheimer's & Dementia. 2: S652-S652. DOI: 10.1016/J.Jalz.2006.05.2196 |
0.448 |
|
| 2006 |
Nordberg AK, Wall A, Almkvist O, Hagman G, Engler H, Forsberg A, Kadir A, Andreasen N, Blomquist G, Långström B. O2-05-03: Effect of phenserine treatment on PIB amyloid binding, cerebral glucose metabolism and cognition in mild Alzheimer patients Alzheimer's & Dementia. 2: S40-S40. DOI: 10.1016/J.Jalz.2006.05.140 |
0.427 |
|
| 2006 |
Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. P2-304: PET imaging of cortical 11
C-nicotine binding correlates with cognitive function of attention in Alzheimer's disease Alzheimer's & Dementia. 2: S329-S329. DOI: 10.1016/J.Jalz.2006.05.1144 |
0.603 |
|
| 2006 |
Forsberg A, Engler H, Blomquist G, Almkvist O, Hagman G, Wall A, Ringheim A, Långström B, Nordberg A. P2-303: Amyloid depositions in MCI-patients studied with PIB-PET Alzheimer's & Dementia. 2: S329-S329. DOI: 10.1016/J.Jalz.2006.05.1143 |
0.585 |
|
| 2006 |
Almkvist O. S2-04-05: What are neuropsychological criteria for differential diagnosis of dementia syndromes Alzheimer's & Dementia. 2: S29-S29. DOI: 10.1016/J.Jalz.2006.05.099 |
0.479 |
|
| 2005 |
Wahlund LO, Almkvist O, Blennow K, Engedahl K, Johansson A, Waldemar G, Wolf H. Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup. Topics in Magnetic Resonance Imaging : Tmri. 16: 427-37. PMID 17088692 DOI: 10.1097/01.Rmr.0000245463.36148.12 |
0.316 |
|
| 2005 |
Ek L, Smits A, Påhlson A, Almkvist O. Analysis of Cognitive Dysfunction in Patients with Low-Grade Glioma Journal of Clinical Psychology in Medical Settings. 12: 165-173. DOI: 10.1007/S10880-005-3276-7 |
0.303 |
|
| 2004 |
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine. 256: 240-6. PMID 15324367 DOI: 10.1111/J.1365-2796.2004.01380.X |
0.519 |
|
| 2004 |
Arnáiz E, Almkvist O, Ivnik RJ, Tangalos EG, Wahlund LO, Winblad B, Petersen RC. Mild cognitive impairment: a cross-national comparison. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1275-80. PMID 15314114 DOI: 10.1136/Jnnp.2003.015032 |
0.379 |
|
| 2004 |
Amberla K, Wäljas M, Tuominen S, Almkvist O, Pöyhönen M, Tuisku S, Kalimo H, Viitanen M. Insidious cognitive decline in CADASIL. Stroke; a Journal of Cerebral Circulation. 35: 1598-602. PMID 15143298 DOI: 10.1161/01.Str.0000129787.92085.0A |
0.377 |
|
| 2004 |
Almkvist O, Darreh-Shori T, Stefanova E, Spiegel R, Nordberg A. Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 11: 253-61. PMID 15061827 DOI: 10.1046/J.1468-1331.2003.00757.X |
0.602 |
|
| 2004 |
Stefanova E, Axelman K, Almkvist O, Wall A, Lannfelt L, Lngström B, Nordberg A. P3-083 FDG PET reveals decreased cerebral glucose metabolism in presymptomatic carriers of the HIS163TYR mutation in the presenilin-1 gene at risk for developing familial Alzheimer's disease Neurobiology of Aging. 25: S377. DOI: 10.1016/S0197-4580(04)81235-1 |
0.575 |
|
| 2004 |
Arnaiz E, Wahlund L, Winblad B, Almkvist O. P1-127 Subtypes of mild cognitive impairment: cognitive characteristics related to risk factors Neurobiology of Aging. 25: S131. DOI: 10.1016/S0197-4580(04)80440-8 |
0.352 |
|
| 2004 |
Nordberg A, Engler H, Blomqvist G, Almkvist O, Ausén B, Wall A, Lngström B. O3-03-08 Imaging of amyloid in brain in vivo in MCI and AD patients Neurobiology of Aging. 25: S59. DOI: 10.1016/S0197-4580(04)80198-2 |
0.538 |
|
| 2004 |
Almkvist O, Arnaiz E, Winblad B. O2-02-02 CSF levels of total TAU, phosphorylated TAU and β-amyloid as indices of clinical status in individuals refered to a memory clinic Neurobiology of Aging. 25: S34. DOI: 10.1016/S0197-4580(04)80112-X |
0.324 |
|
| 2003 |
Almkvist O. Cognitive syndrome(s) in preclinical and clinical vascular dementia. International Psychogeriatrics. 15: 127-31. PMID 16191229 DOI: 10.1017/S1041610203009086 |
0.369 |
|
| 2003 |
Engstad T, Almkvist O, Viitanen M, Arnesen E. Impaired motor speed, visuospatial episodic memory and verbal fluency characterize cognition in long-term stroke survivors: the Tromsø Study. Neuroepidemiology. 22: 326-31. PMID 14557682 DOI: 10.1159/000072921 |
0.306 |
|
| 2003 |
Axelman K, Lannfelt L, Almkvist O, Carlsson M. Life situation, coping and quality of life in people with high and low risk of developing Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 16: 220-8. PMID 14512717 DOI: 10.1159/000072806 |
0.314 |
|
| 2003 |
Huang C, Wahlund LO, Almkvist O, Elehu D, Svensson L, Jonsson T, Winblad B, Julin P. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage. 19: 1137-44. PMID 12880839 DOI: 10.1016/S1053-8119(03)00168-X |
0.407 |
|
| 2003 |
Almkvist O, Axelman K, Basun H, Jensen M, Viitanen M, Wahlund LO, Lannfelt L. Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairment. Acta Neurologica Scandinavica. Supplementum. 179: 77-82. PMID 12603253 DOI: 10.1034/J.1600-0404.107.S179.11.X |
0.45 |
|
| 2003 |
Arnáiz E, Almkvist O. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurologica Scandinavica. Supplementum. 179: 34-41. PMID 12603249 DOI: 10.1034/J.1600-0404.107.S179.7.X |
0.483 |
|
| 2003 |
Lindau M, Jelic V, Johansson SE, Andersen C, Wahlund LO, Almkvist O. Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 15: 106-14. PMID 12566600 DOI: 10.1159/000067973 |
0.514 |
|
| 2003 |
Stefanova E, Blennow K, Almkvist O, Hellström-Lindahl E, Nordberg A. Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients. Neuroscience Letters. 338: 159-63. PMID 12566177 DOI: 10.1016/S0304-3940(02)01384-8 |
0.588 |
|
| 2003 |
Lundberg C, Hakamies-Blomqvist L, Almkvist O, Johansson K. License Suspension Revisited: A 3-Year Follow-Up Study of Older Drivers Journal of Applied Gerontology. 22: 427-444. DOI: 10.1177/0733464803254007 |
0.311 |
|
| 2002 |
Almkvist O, Axelman K, Basun H, Wahlund LO, Lannfelt L. Conversion from preclinical to dinical stage of Alzheimer's disease as shown by decline of cognitive function in carriers of the Swedish APP-mutation. Journal of Neural Transmission. Supplementum. 117-25. PMID 12456057 DOI: 10.1007/978-3-7091-6139-5_12 |
0.473 |
|
| 2002 |
Fahlander K, Wahlin A, Almkvist O, Bäckman L. Cognitive functioning in Alzheimer's disease and vascular dementia: further evidence for similar patterns of deficits. Journal of Clinical and Experimental Neuropsychology. 24: 734-44. PMID 12424648 DOI: 10.1076/Jcen.24.6.734.8404 |
0.489 |
|
| 2002 |
Darreh-Shori T, Almkvist O, Guan ZZ, Garlind A, Strandberg B, Svensson AL, Soreq H, Hellström-Lindahl E, Nordberg A. Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology. 59: 563-72. PMID 12196650 DOI: 10.1212/Wnl.59.4.563 |
0.496 |
|
| 2001 |
Tallberg IM, Almkvist O. Confabulation and memory in patients with Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 23: 172-84. PMID 11309671 DOI: 10.1076/Jcen.23.2.172.1215 |
0.407 |
|
| 2001 |
Ingelson M, Fabre SF, Lilius L, Andersen C, Viitanen M, Almkvist O, Wahlund LO, Lannfelt L. Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4. Neuroreport. 12: 905-9. PMID 11303757 DOI: 10.1097/00001756-200104170-00008 |
0.398 |
|
| 2001 |
Arnáiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, Nordberg A. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport. 12: 851-5. PMID 11277595 DOI: 10.1097/00001756-200103260-00045 |
0.608 |
|
| 2001 |
Almkvist O. Functional brain imaging as a looking-glass into the degraded brain: reviewing evidence from Alzheimer disease in relation to normal aging. Acta Psychologica. 105: 255-77. PMID 11194415 DOI: 10.1016/S0001-6918(00)00064-0 |
0.372 |
|
| 2001 |
Fernaeus SE, Almkvist O, Bronge L, Ostberg P, Hellström A, Winblad B, Wahlund LO. White matter lesions impair initiation of FAS flow. Dementia and Geriatric Cognitive Disorders. 12: 52-6. PMID 11125241 DOI: 10.1159/000051235 |
0.347 |
|
| 2001 |
Almkvist O, Jelic V, Amberla K, Hellström-Lindahl E, Meurling L, Nordberg A. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. Dementia and Geriatric Cognitive Disorders. 12: 22-32. PMID 11125238 DOI: 10.1159/000051232 |
0.519 |
|
| 2000 |
Winblad B, Wimo A, Almkvist O. Outcome measures in Alzheimer's disease: do they go far enough? Dementia and Geriatric Cognitive Disorders. 3-10. PMID 10971046 DOI: 10.1159/000051226 |
0.43 |
|
| 2000 |
Lindau M, Almkvist O, Kushi J, Boone K, Johansson SE, Wahlund LO, Cummings JL, Miller BL. First symptoms--frontotemporal dementia versus Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 11: 286-93. PMID 10940680 DOI: 10.1159/000017251 |
0.4 |
|
| 2000 |
Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Nordberg A, Winblad B, Wahlund LO. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiology of Aging. 21: 533-40. PMID 10924766 DOI: 10.1016/S0197-4580(00)00153-6 |
0.565 |
|
| 2000 |
Bäckman L, Almkvist O, Nyberg L, Andersson J. Functional changes in brain activity during priming in Alzheimer's disease. Journal of Cognitive Neuroscience. 12: 134-41. PMID 10769311 DOI: 10.1162/089892900561922 |
0.468 |
|
| 2000 |
Almkvist O, Winblad B. Early diagnosis of Alzheimer dementia based on clinical and biological factors. European Archives of Psychiatry and Clinical Neuroscience. 3-9. PMID 10654093 DOI: 10.1007/Pl00014171 |
0.485 |
|
| 2000 |
Arnaiz E, Almkvist O. Apolipoprotein E genotype does not influence course of cognitive decline in mild cognitive impairment and Alzheimer's disease Neurobiology of Aging. 21: 231. DOI: 10.1016/S0197-4580(00)83375-8 |
0.431 |
|
| 1999 |
Almkvist O, Fratiglioni L, Agüero-Torres H, Viitanen M, Bäckman L. Cognitive support at episodic encoding and retrieval: similar patterns of utilization in community-based samples of Alzheimer's disease and vascular dementia patients. Journal of Clinical and Experimental Neuropsychology. 21: 816-30. PMID 10649536 DOI: 10.1076/Jcen.21.6.816.862 |
0.426 |
|
| 1999 |
Wahlund LO, Basun H, Almkvist O, Julin P, Axelman K, Shigeta M, Jelic V, Nordberg A, Lannfelt L. A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation. Dementia and Geriatric Cognitive Disorders. 10: 526-33. PMID 10559570 DOI: 10.1159/000017200 |
0.599 |
|
| 1999 |
Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, Kennedy A, Hasselbalch S, Fazio F, Heiss WD. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 10: 494-504. PMID 10559566 DOI: 10.1159/000017196 |
0.624 |
|
| 1999 |
Bäckman L, Andersson JL, Nyberg L, Winblad B, Nordberg A, Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology. 52: 1861-70. PMID 10371535 DOI: 10.1212/Wnl.52.9.1861 |
0.543 |
|
| 1999 |
Ji Y, Urakami K, Adachi Y, Nakashima K, Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, ... ... Almkvist O, et al. Contents Vol. 10, 1999 Dementia and Geriatric Cognitive Disorders. 10: 553-555. DOI: 10.1159/000017205 |
0.367 |
|
| 1999 |
Ji Y, Urakami K, Adachi Y, Nakashima K, Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, ... ... Almkvist O, et al. Subject Index Vol. 10, 1999 Dementia and Geriatric Cognitive Disorders. 10: 551-552. DOI: 10.1159/000017204 |
0.392 |
|
| 1998 |
Almkvist O, Basun H, Bäckman L, Herlitz A, Lannfelt L, Small B, Viitanen M, Wahlund LO, Winblad B. Mild cognitive impairment--an early stage of Alzheimer's disease? Journal of Neural Transmission. Supplementum. 54: 21-9. PMID 9850912 DOI: 10.1007/978-3-7091-7508-8_3 |
0.485 |
|
| 1998 |
Jelic V, Dierks T, Amberla K, Almkvist O, Winblad B, Nordberg A. Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease. Neuroscience Letters. 254: 85-8. PMID 9779926 DOI: 10.1016/S0304-3940(98)00669-7 |
0.523 |
|
| 1998 |
Lindau M, Almkvist O, Johansson SE, Wahlund LO. Cognitive and behavioral differentiation of frontal lobe degeneration of the non-Alzheimer type and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 9: 205-13. PMID 9681642 DOI: 10.1159/000017048 |
0.488 |
|
| 1998 |
Lundberg C, Hakamies-Blomqvist L, Almkvist O, Johansson K. Impairments of some cognitive functions are common in crash-involved older drivers. Accident; Analysis and Prevention. 30: 371-7. PMID 9663296 DOI: 10.1016/S0001-4575(97)00111-5 |
0.32 |
|
| 1998 |
Julin P, Almkvist O, Basun H, Lannfelt L, Svensson L, Winblad B, Wahlund LO. Brain volumes and regional cerebral blood flow in carriers of the Swedish Alzheimer amyloid protein mutation. Alzheimer Disease and Associated Disorders. 12: 49-53. PMID 9539411 DOI: 10.1097/00002093-199803000-00008 |
0.446 |
|
| 1997 |
Bäckman L, Almkvist O, Andersson J, Nordberg A, Winblad B, Reineck R, Långström B. Brain activation in young and older adults during implicit and explicit retrieval. Journal of Cognitive Neuroscience. 9: 378-91. PMID 23965013 DOI: 10.1162/Jocn.1997.9.3.378 |
0.438 |
|
| 1997 |
Yagyu T, Wackermann J, Shigeta M, Jelic V, Kinoshita T, Kochi K, Julin P, Almkvist O, Wahlund LO, Kondakor I, Lehmann D. Global dimensional complexity of multichannel EEG in mild Alzheimer's disease and age-matched cohorts. Dementia and Geriatric Cognitive Disorders. 8: 343-7. PMID 9370086 DOI: 10.1159/000106653 |
0.438 |
|
| 1997 |
Andersen C, Dahl C, Almkvist O, Ostberg P, Julin P, Wahlund LO. Bilateral temporal lobe volume reduction parallels cognitive impairment in progressive aphasia. Archives of Neurology. 54: 1294-9. PMID 9341577 DOI: 10.1001/Archneur.1997.00550220092020 |
0.376 |
|
| 1997 |
Dierks T, Jelic V, Julin P, Maurer K, Wahlund LO, Almkvist O, Strik WK, Winblad B. EEG-microstates in mild memory impairment and Alzheimer's disease: possible association with disturbed information processing. Journal of Neural Transmission (Vienna, Austria : 1996). 104: 483-95. PMID 9295180 DOI: 10.1007/Bf01277666 |
0.367 |
|
| 1997 |
Nordin S, Almkvist O, Berglund B, Wahlund LO. Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease. Archives of Neurology. 54: 993-8. PMID 9267974 DOI: 10.1001/Archneur.1997.00550200051010 |
0.448 |
|
| 1997 |
Small BJ, Herlitz A, Fratiglioni L, Almkvist O, Bäckman L. Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study. Neuropsychology. 11: 413-20. PMID 9223145 DOI: 10.1037/0894-4105.11.3.413 |
0.462 |
|
| 1997 |
Almkvist O, Basun H, Wagner SL, Rowe BA, Wahlund LO, Lannfelt L. Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation. Archives of Neurology. 54: 641-4. PMID 9152122 DOI: 10.1001/Archneur.1997.00550170111022 |
0.455 |
|
| 1997 |
Basun H, Almkvist O, Axelman K, Brun A, Campbell TA, Collinge J, Forsell C, Froelich S, Wahlund LO, Wetterberg L, Lannfelt L. Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementia. Archives of Neurology. 54: 539-44. PMID 9152110 DOI: 10.1001/Archneur.1997.00550170021010 |
0.354 |
|
| 1997 |
Herlitz A, Small BJ, Fratiglioni L, Almkvist O, Viitanen M, Bäckman L. Detection of mild dementia in community surveys. Is it possible to increase the accuracy of our diagnostic instruments? Archives of Neurology. 54: 319-24. PMID 9074402 DOI: 10.1001/Archneur.1997.00550150075019 |
0.365 |
|
| 1997 |
Hellström A, Almkvist O. Tone duration discrimination in demented, memory-impaired, and healthy elderly. Dementia and Geriatric Cognitive Disorders. 8: 49-54. PMID 8997552 DOI: 10.1159/000106600 |
0.411 |
|
| 1997 |
Almkvist O, Bråne G, Johanson A. Neuropsychological assessment of dementia: state of the art. Acta Neurologica Scandinavica. Supplementum. 168: 45-9. PMID 8997419 DOI: 10.1111/J.1600-0404.1996.Tb00372.X |
0.394 |
|
| 1997 |
Jelic V, Shigeta M, Julin P, Almkvist O, Winblad B, Wahlund LO. Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. Dementia (Basel, Switzerland). 7: 314-23. PMID 8915037 DOI: 10.1159/000106897 |
0.448 |
|
| 1997 |
Small BJ, Herlitz A, Fratiglioni L, Almkvist O, Bäckman L. Cognitive predictors of incident Alzheimer's disease: A prospective longitudinal study. Neuropsychology. 11: 413-420. DOI: 10.1037/0894-4105.11.3.413 |
0.357 |
|
| 1997 |
Lindqvist J, Julin P, Schmeeling B, Almkvist O, Wahlund L. MRI brain volumetry using computerized stereology in memory impairment and Alzheimer's disease Psychiatry Research: Neuroimaging. 68: 171. DOI: 10.1016/S0925-4927(97)81554-5 |
0.413 |
|
| 1997 |
Julin P, Svensson L, Almkvist O, Måhre K, Wahlund L. MRI-guided SPECT-measurements of medial temporal lobe blood flow in Alzheimer's disease Psychiatry Research: Neuroimaging. 68: 166-167. DOI: 10.1016/S0925-4927(97)81538-7 |
0.367 |
|
| 1996 |
Algotsson A, Nordberg A, Lannfelt L, Almkvist O, Winblad B. Apolipoprotein E epsilon4 allele, skin vessel reactivity and vascular risk factors in Alzheimer's disease. Archives of Gerontology and Geriatrics. 22: 223-32. PMID 15374172 DOI: 10.1016/0167-4943(96)00695-4 |
0.516 |
|
| 1996 |
Almkvist O. Neuropsychological features of early Alzheimer's disease: preclinical and clinical stages. Acta Neurologica Scandinavica. Supplementum. 165: 63-71. PMID 8740991 DOI: 10.1111/J.1600-0404.1996.Tb05874.X |
0.451 |
|
| 1996 |
Shigeta M, Jelic V, Usui M, Kinoshita T, Lehmann D, Julin P, Almkvist O, Winblad B, Wahlund L-. 658 Changes of EEG model source localisation in Alzheimer's disease Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80660-9 |
0.391 |
|
| 1996 |
Lindau M, Johansson S, Wahlund L, Almkvist O. 593 Frontal lobe dementia and Alzheimer's disease are clinically separable using behavioral observations and cognitive function assessment Neurobiology of Aging. 17: S147-S148. DOI: 10.1016/S0197-4580(96)80595-1 |
0.454 |
|
| 1996 |
Julin P, Jelic V, Shigetal M, Almkvist O, Svensson L, Slomka P, Wahlund L. 454 Combined measurement of regional brain volume and perfusion in Alzheimer's disease using coregistred MRI/SPECT Neurobiology of Aging. 17: S113. DOI: 10.1016/S0197-4580(96)80456-8 |
0.409 |
|
| 1996 |
Jelic V, Almkvist O, Julin P, Wahlund L, Winblad B, Nordberg A. 367 Patterns of brain metabolism in patients with mild cognitive impairment Neurobiology of Aging. 17: S92. DOI: 10.1016/S0197-4580(96)80369-1 |
0.52 |
|
| 1995 |
Algotsson A, Nordberg A, Almkvist O, Winblad B. Skin vessel reactivity is impaired in Alzheimer's disease. Neurobiology of Aging. 16: 577-82. PMID 8544908 DOI: 10.1016/0197-4580(95)00077-R |
0.53 |
|
| 1995 |
Shigeta M, Julin P, Almkvist O, Basun H, Rudberg U, Wahlund LO. EEG in successful aging; a 5 year follow-up study from the eighth to ninth decade of life. Electroencephalography and Clinical Neurophysiology. 95: 77-83. PMID 7649008 DOI: 10.1016/0013-4694(95)00034-V |
0.305 |
|
| 1995 |
Shigeta M, Jelic V, Kinoshita T, Lehmann D, Hyoki K, Julin P, Almkvist O, Johansson K, Wahlund L. PS-27-3 Anterior and superior shifting of EEG source locations as probes of mild Alzheimer's disease Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control. 97: S151. DOI: 10.1016/0924-980X(95)92981-Q |
0.411 |
|
| 1994 |
Ericsson K, Hillerås P, Holmén K, Jorm A, Forssell LG, Almkvist O, Rönnberg L, Winblad B. The short human figure drawing scale for evaluation of suspect cognitive dysfunction in old age. Archives of Gerontology and Geriatrics. 19: 243-51. PMID 15374270 DOI: 10.1016/0167-4943(94)00567-2 |
0.349 |
|
| 1994 |
Almkvist O, Bäckman L, Basun H, Wahlund LO. Patterns of neuropsychological performance in Alzheimer's disease and vascular dementia. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 29: 661-73. PMID 8124942 DOI: 10.1016/S0010-9452(13)80289-4 |
0.467 |
|
| 1994 |
Almkvist O. Neuropsychological deficits in vascular dementia in relation to Alzheimer's disease: reviewing evidence for functional similarity or divergence. Dementia (Basel, Switzerland). 5: 203-9. PMID 8087181 DOI: 10.1159/000106724 |
0.446 |
|
| 1994 |
Wahlund LO, Basun H, Almkvist O, Andersson-Lundman G, Julin P, Sääf J. White matter hyperintensities in dementia: does it matter? Magnetic Resonance Imaging. 12: 387-94. PMID 8007767 DOI: 10.1016/0730-725X(94)92531-3 |
0.478 |
|
| 1994 |
Sjögren B, Ljunggren KG, Almkvist O, Frech W, Basun H. Aluminosis and dementia. Lancet (London, England). 344: 1154. PMID 7934507 DOI: 10.1016/S0140-6736(94)90659-9 |
0.371 |
|
| 1993 |
Wahlund LO, Andersson-Lundman G, Basun H, Almkvist O, Björkstén KS, Sääf J, Wetterberg L. Cognitive functions and brain structures: a quantitative study of CSF volumes on Alzheimer patients and healthy control subjects. Magnetic Resonance Imaging. 11: 169-74. PMID 8455428 DOI: 10.1016/0730-725X(93)90021-5 |
0.406 |
|
| 1993 |
Almkvist O, Bäckman L. Progression in alzheimer's disease: Sequencing of neuropsychological decline International Journal of Geriatric Psychiatry. 8: 755-763. DOI: 10.1002/Gps.930080908 |
0.446 |
|
| 1992 |
Almkvist O, Wahlund LO, Andersson-Lundman G, Basun H, Bäckman L. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Archives of Neurology. 49: 626-32. PMID 1596198 DOI: 10.1001/Archneur.1992.00530300062011 |
0.407 |
|
| 1992 |
Almkvist O, Bäckman L. Progression of neuropsychological functions in Alzheimer's disease Neurobiology of Aging. 13: S4. DOI: 10.1016/0197-4580(92)90136-L |
0.334 |
|
| Show low-probability matches. |